Skip to main content
Caplight Logo









Mitrix Bio

Mitrix Bio

Private
Pleasanton, CaliforniaHealthcare & Life Scienceshttps://mitrix.bio/

Last Round

Pre Seed

Jan 28, 2021

Total Funding Raised

$500,000

Company Overview

Mitrix Bio is a preclinical research company developing mitochondrial transfusion technology to combat aging-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Medical Devices

Business Model

B2B2C

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

mitochondrial transplantationregenerative medicinelongevity biotechhealthspan extensionmitochondria therapyanti-aging therapycellular rejuvenationbioreactor technologyautologous therapymitochondria productionMitletsmitochondrial dysfunctionRight to Tryage-related diseasesMitoClockexperimental therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mitrix Bio Comparables

Compare Mitrix Bio with similar companies based on industry and business-model similarity.

Mitrix Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MitoSense, Inc.
87%
Cellergy Therapeutics
82%
PAEAN Biotechnology
79%

Mitrix Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJan 28, 2021
Pre SeedJan 1, 2021

Key People

Founding team and executive leadership

Kyle Cetrulo

Chief Operating Officer, Interim Chief Operations Officer

Executive Team

Mitrix Bio Investors

Notable investors and investment history

Mitrix Bio investors
InvestorRounds
R42 GroupPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 25, 2026

    Monthly visitors increased 51% MoM, reaching 3.2K.

  • Jun 1, 2025

    Monthly visitors increased 47% MoM, reaching 2.5K.

Mitrix Bio Filings

Explore SEC and related filing metadata, where available.

Mitrix Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mitrix Bio's valuation, stock price, and market status.

Is Mitrix Bio a public or private company?

Mitrix Bio is a private company.

What is the current stock price of Mitrix Bio?

Mitrix Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Mitrix Bio worth (valuation)?

Valuation information for Mitrix Bio is not publicly available.

Can I buy Mitrix Bio stock?

Mitrix Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Mitrix Bio's last funding round?

Mitrix Bio's most recent funding round was Pre Seed on January 28, 2021.

Who are the main investors in Mitrix Bio?

Key investors in Mitrix Bio include R42 Group.

Will Mitrix Bio IPO soon?

No public IPO plans have been announced for Mitrix Bio.

How can I track Mitrix Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mitrix Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPleasanton, California
Employee Range11
Year Founded2018
Last FundingJan 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?